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S U M M A R Y
Objectives: The aim of the present study was to identify and differentiate Mycobacterium kansasii and
Mycobacterium chelonae–Mycobacterium abscessus group strains isolated from clinical and environmen-
tal sources in different countries.
Methods: PCR-restriction analysis of the hsp65 gene (PRA) with automated capillary electrophoresis was
applied to the isolates previously identiﬁed by conventional biochemical testing and the molecular
INNO-LiPA MYCOBACTERIA assay.
Results: PRA performed very well in comparison with the two other methods (96.4% concordance).
Among 27 M. kansasii isolates, this method detected ﬁve genetic types, of which type 1 represented the
most common clinical isolate, as it is worldwide. PRA differentiated 29 M. chelonae–M. abscessus group
isolates into Mycobacterium immunogenum type 2 (n = 13), M. chelonae (n = 12), and M. abscessus types 1
(n = 1) and 2 (n = 1). M. immunogenum was the most frequent (69%) isolate from humans, but only one of
11 cases was clinically signiﬁcant. M. chelonae was the most commonly (83%) recovered from water. PRA
also identiﬁed two isolates with hsp65 alleles representing previously unreported patterns.
Conclusions: PRA based on automated capillary electrophoresis is a rapid, simple, and reliable method
for the identiﬁcation and differentiation of both clinically relevant and environmental isolates of M.
kansasii and M. chelonae–M. abscessus group.
 2012 International Society for Infectious Diseases. Published by Elsevier Ltd. All rights reserved.
Contents lists available at SciVerse ScienceDirect
International Journal of Infectious Diseases
jou r nal h o mep ag e: w ww .e lsev ier . co m / loc ate / i j id1. Introduction
Among the most frequently isolated clinical strains of non-
tuberculous mycobacteria (NTM) are Mycobacterium kansasii and
Mycobacterium chelonae–Mycobacterium abscessus group.1 M.
kansasii is best known as a cause of lung disease in immunocom-
petent patients, although it may also produce pulmonary or
disseminated infections in HIV-infected patients.2,3 M. chelonae
has been implicated in localized or disseminated infections and
health care-associated disease, and M. abscessus can cause chronic
lung disease.4,5 Mycobacterium immunogenum is related to
metalworking ﬂuid-associated hypersensitivity pneumonitis,6
and the newly described Mycobacterium massiliense7 and Myco-
bacterium bolletii8 to skin and soft tissue infections.9,10
Identiﬁcation of mycobacteria to the species level is necessary
for the application of adequate drug therapy and to address
epidemiological questions. Conventional identiﬁcation techniques
based on the culture and biochemical characteristics of acid-fast* Corresponding author. Tel.: +48 42 635 4772; fax: +48 42 665 5818.
E-mail address: asajduda@biol.uni.lodz.pl (A. Sajduda).
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doi:10.1016/j.ijid.2011.11.011isolates are the most commonly used methods for the determina-
tion of mycobacterial species, but these procedures are time-
consuming and labor-intensive. The development of molecular
tests has speeded up diagnosis, but most methods suffer from
speciﬁc drawbacks. The INNO-LiPA MYCOBACTERIA assay (LiPA;
Innogenetics, Ghent, Belgium), a commercially available assay
targeting the 16S–23S internal transcribed spacer (ITS) region, was
developed for the current identiﬁcation of 16 species (including M.
kansasii and M. chelonae). The assay is highly speciﬁc and sensitive,
but its cost remains high and it cannot differentiate the members
of the M. chelonae–M. abscessus group.11 Moreover, the correlation
of each of the three possible hybridization patterns (MCH-1, MCH-
2, and MCH-3) with the members of this group has not yet been
fully evaluated. Partial sequencing of conserved genes and DNA
regions such as the 16S rRNA gene, ITS, rpoB, hsp65, sodA, and the
new target secA, is the most sensitive and accurate, but still
expensive and technically demanding, procedure for the identiﬁ-
cation of mycobacterial species.9,10,12–14
Restriction enzyme analysis of PCR products of speciﬁc genes
generates mostly species-speciﬁc DNA patterns, and provides a
comparatively cheap alternative over DNA sequencing. In particu-
lar, PCR-restriction analysis (PRA) of part of the gene encoding theses. Published by Elsevier Ltd. All rights reserved.
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diagnostic purposes.9,10,16–18 This method is based on the
ampliﬁcation of a 441-bp fragment of the hsp65 gene present in
all mycobacteria, followed by digestion of the PCR product with the
restriction enzymes BstEII and HaeIII. By combining both restric-
tion patterns a species assignment is possible based on comparison
with patterns described in published algorithms15,16 or available
from an Internet database (http://app.chuv.ch/prasite).
The aim of this study was to evaluate the hsp65 PRA with an
automated capillary electrophoresis in the identiﬁcation and
differentiation of M. kansasii and M. chelonae–M. abscessus group
in a reference laboratory. The results were compared to
identiﬁcation by conventional methods and the commercial LiPA
assay.
2. Materials and methods
2.1. Mycobacterial strains
A total of 56 cultured isolates studied here were selected on the
basis of their origins from different sources and geographical areas.
They included 27 M. kansasii isolates from Belgium (n = 13),
Germany (n = 7), and the Czech Republic (n = 7). These isolates
were recovered from human (n = 15), environmental (n = 11), and
animal (n = 1) sources. All of the environmental M. kansasii strains
were isolated from tap water. Twenty-nine strains of M. chelonae–
M. abscessus group were isolated in Belgium (n = 15), Germany
(n = 13), and Colombia (n = 1). These strains were of human
(n = 16) and environmental (n = 13) origin. Two of the environ-
mental isolates were recovered from river surface water, while the
remaining strains were isolated from tap water. All of the strains
had previously been identiﬁed as M. kansasii or M. chelonae–M.
abscessus by conventional phenotypic methods and the LiPA assay
(INNO-LiPA MYCOBACTERIA, Innogenetics, Ghent, Belgium).19
Reference strains of M. kansasii (ATCC 12478), M. chelonae
(ATCC 35752), and M. abscessus (ATCC 19977) were used. The
bacterial strains were stored at 70 8C in Dubos broth with 9.5%
glycerol. Prior to use, the strains were subcultured onto Lo¨w-
enstein–Jensen medium slants.
2.2. hsp65 PRA
PCR-restriction enzyme analysis of the hsp65 gene (hsp65 PRA)
was performed for all isolates and reference strains as previously
described by Telenti et al.,15 with minor modiﬁcations.20
Restriction products were electrophoresed both on a 3% agarose
gel prepared in 1  TBE (Tris–borate–EDTA) buffer and sized with
50- and 25-bp DNA ladders (Promega, Madison, WI, USA) and by
automated ﬂuorescence capillary electrophoresis using the Agilent
2100 bioanalyzer (Agilent Technologies, Waldbronn, Germany) for
more accurate determination of fragment sizes. For the latterTable 1
Genotypic characterization of Mycobacterium kansasii by PRA
PRA type No. of isolates 
Human (n = 16) Environmental (n = 11) Animal (n = 1) 
1 12b 1 0 
2 4 2 1 
3 0 5 0 
4 0 2 0 
5 0 1 0 
PRA, PCR-restriction analysis.
a Fragment sizes determined by agarose gel electrophoresis are in parentheses, wh
Bioanalyzer) are without them. Sizes are average of the results obtained for M. kansasii str
in a single strain.
b Including the M. kansasii reference strain.purpose, aliquots of restriction digests were ethanol-precipitated
and 1-ml samples were then electrophoresed and analyzed using
the DNA 1000 LabChip1 kit in accordance with the manufacturer’s
instructions.
The observed PRA patterns were interpreted ﬁrst by compari-
son with patterns in our own identiﬁcation table based on
automated capillary electrophoresis.20 Strains with PRA patterns
not matching any of those included in our bioanalyzer system-
based interpretative scheme were identiﬁed using the latest
algorithm published by Chimara et al.16 and also the PRA site
query.
2.3. DNA sequence analysis
For those isolates for which PRA gave inconclusive results due
to patterns unreported so far, the partial hsp65 and rpoB gene
sequences were obtained. A 441-bp fragment of the hsp65 gene
was ampliﬁed as described previously.20 Ampliﬁcation of the 723-
bp rpoB variable region was performed as described by Ade´kambi
et al.14 The PCR primers were also used for the direct sequencing of
both strands of the ampliﬁcation products. Amplicons were
sequenced by VIB Genetic Service Facility, University of Antwerp,
Wilrijk, Belgium with the use of dye terminator reactions followed
by electrophoresis on an automated ABI Prism 377 DNA sequencer
(Applied Biosystems, Foster City, CA, USA). The sequences obtained
were compared with those deposited in the GenBank database
using BLAST (http://www.ncbi.nlm.nih.gov/BLAST/).
3. Results
3.1. Identiﬁcation and genotypic characterization of M. kansasii
strains
There was complete agreement of identiﬁcation results
between all three methods used: (1) conventional phenotypic
methods, (2) the commercial LiPA assay, and (3) hsp65 PRA. The
sizes of restriction fragments produced by the latter method and
measured by the Agilent 2100 bioanalyzer were consistently
smaller than those estimated on the basis of agarose gel
electrophoresis (Tables 1 and 2). Despite those differences, it
provided highly reproducible and sufﬁciently polymorphic pat-
terns necessary for the differentiation of species and PRA types of
species, consistent with our previous observations.20
Restriction enzyme analysis of the hsp65 gene from 27 isolates
and the reference strain detected ﬁve of the six recognized genetic
types of M. kansasii16 (Table 1). Eleven clinical isolates and the
reference strain presented the type 1 PRA pattern, while this
genotype was isolated only once from tap water (shower). Of the
remaining 15 isolates, most (n = 7) presented PRA type 2 pattern,
and this was the most ubiquitous, being recovered four times from
humans, twice from tap water, and also from the single animalRestriction fragments (bp) by hsp65 PRAa
BstEII HaeIII
226 (235), 193 (210) 122 (130), 93 (105), 69 (80)
227 (235), 127 (130), 78 (85) 127 (130), 93 (105)
230 (235), 127 (130), 78 (85) 124 (130), 88 (95), 62 (70)
227 (235), 112 (120), 78 (85) 127 (130), 111 (115), 66 (75), 52 (60)
306 (320), 111 (115) 127 (130), 88 (95), 66 (75), 52 (60)
ereas those estimated by the capillary electrophoresis instrument (Agilent 2100
ains presenting a given type of PRA pattern, except for type 5, which was found only
Table 2
Genetic differentiation of Mycobacterium chelonae–Mycobacterium abscessus group by PRA
Strain and type No. of isolates Restriction fragments (bp) by hsp65 PRAa
Clinical (n = 18) Tap water (n = 11) River water (n = 2) BstEII HaeIII
M. abscessus 1 2b 0 0 224 (235), 197 (210) 141 (145), 61 (70), 50 (60), 43 (55)
M. abscessus 2 1 0 0 227 (235), 199 (210) 190 (200), 62 (70), 51 (60), 39 (50)
M. chelonae 3c 9 1 306 (320), 127 (130) 192 (200), 52 (60), 46 (55), 38 (50)
M. immunogenum 2 11 2 0 304 (320), 127 (130) 190 (200), 63 (70), 52 (60), 46 (55)
New pattern 1 1 0 0 305 (320), 127 (130) 157 (170), 62 (70), 50 (60), 38 (50)
New pattern 2 0 0 1 307 (320), 127 (130) 190 (200), 107 (115), 51 (60), 39 (50)
PRA, PCR-restriction analysis.
a Fragment sizes determined by agarose gel electrophoresis are in parentheses, while those measured by the capillary electrophoresis instrument (Agilent 2100
bioanalyzer) are without them. Sizes are average of the results obtained for the strains presenting a given type of PRA pattern, except for a single isolate of M. abscessus type 2
and two isolates with new patterns.
b Including the M. abscessus reference strain.
c Including the M. chelonae reference strain.
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(n = 2), and 5 (n = 1) were all isolated from tap water.
3.2. Identiﬁcation and differentiation of M. chelonae–M. abscessus
group
Of the 29 strains previously identiﬁed as M. chelonae–M.
abscessus by conventional testing and the molecular LiPA assay, 27
(93%) isolates also yielded concordant results in the hsp65 PRA.
Moreover, PRA enabled further differentiation of these strains to
member species and PRA types of species, which was not possible
with the other methods. The results of identiﬁcation of 29 M.
chelonae–M. abscessus group isolates and the two reference strains
are presented in Figure 1 and Table 2. Most of the clinical isolates
(n = 11) gave the hsp65 PRA patterns corresponding to M.
immunogenum type 2. All these strains were isolated from
respiratory specimens. M. immunogenum type 2 was only isolated
twice from tap water. On the other hand, M. chelonae was the mostFigure 1. Electrophoretic gel image of PRA patterns resulting from BstEII (lanes 1–6) and
representative isolates obtained by using the bioanalyzer system. Lanes: L, DNA ladder;
immunogenum 2; 5 and 11, new pattern 2; 6 and 12, new pattern 1. The 15- and 1500frequently recovered from the environment (nine times from tap
water and once from river surface water) and was only recovered
twice from human respiratory samples. Of the remaining two
clinical isolates from patient sputa, one had a pattern that matched
M. abscessus type 1, and the other was identiﬁed as M. abscessus
type 2. These two genotypes were not found in environmental
samples. The reference strain of M. abscessus presented the type 1
PRA pattern.
For two (7%) of the isolates studied, PRA patterns did not match
any of those in available databases (Figure 1 and Table 2). The two
isolates with inconclusive results were subjected to partial
sequence determination of the hsp65 and rpoB genes, which are
widely studied molecular targets for identiﬁcation purposes, using
the BLAST search against the GenBank database (Table 3). The
isolate with new PRA pattern 1 was recovered from a bronchial
aspirate from a patient in Belgium. Following sequencing of its
rpoB amplicon, an unambiguous species assignment could not be
achieved since that sequence yielded the highest (97%) match to HaeIII (lanes 7–12) digestion of the hsp65 gene of M. chelonae–M. abscessus group
 1 and 7, M. abscessus 1; 2 and 8, M. abscessus 2; 3 and 9, M. chelonae; 4 and 10, M.
-bp bands in all lanes represent lower and upper internal size markers.
Table 3
Evaluation of two inconclusive PRA identiﬁcation results using sequence analysis of the hsp65 and rpoB genes with the GenBank databasea
Conventional and LiPA identiﬁcation hsp65 PRAb hsp65 rpoB
Species % Identity Species % Identity
M. chelonae–M. abscessus New pattern 1 (320/130–170/70/60/50) M. immunogenum 99.0 M. immunogenum/M. chelonae 97.0
New pattern 2 (320/130–200/115/60/50) M. salmoniphilum 99.0 M. salmoniphilum 100
a The data for the ﬁnal identiﬁcation by sequencing of the hsp65 and rpoB genes are provided along with the values indicating the percentage of identity observed for the
best matching sequence available in the database.
b Fragment sizes (bp) after digestion (BstEII–HaeIII), obtained with the use of an agarose gel electrophoresis, are presented in parentheses.
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shared the highest identity (99%) with the M. immunogenum
sequence. For the remaining isolate, which exhibited new PRA
pattern 2, DNA sequencing gave concordant results. The isolate
showed 100% identity with rpoB sequence and 99% identity with
hsp65 sequence of Mycobacterium salmoniphilum. This isolate
originated from river surface water in Germany.
4. Discussion
In recent years the identiﬁcation of mycobacterial isolates to
the species level has been speeded up and simpliﬁed by the use of
molecular techniques, of which hsp65 PRA has the greatest
potential for being widely used as a quick method for identifying
all mycobacteria.2,15–17 Speciﬁcally, PRA with capillary electro-
phoresis can be used to increase the accuracy and rapidity of the
identiﬁcation process.21,22 In this study, we aimed to identify and
differentiate M. kansasii and M. chelonae–M. abscessus group
isolates with the use of automated capillary electrophoresis-based
PRA and our previously constructed diagnostic scheme.20
The results obtained using the automated ﬂuorescence capillary
electrophoresis instrument agreed with the results obtained with
the same strains using conventional agarose gel electrophoresis.
The three reference strains and 54 of 56 (96.4%) test isolates of M.
kansasii (n = 27) and M. chelonae–M. abscessus group (n = 27) were
correctly identiﬁed by PRA despite differences (average 8.5 bp) in
band sizes measured automatically by the bioanalyzer system and
estimated on the basis of 3% agarose gel electrophoresis. The
obtained PRA patterns were highly reproducible and allowed
accurate and fast identiﬁcation of the Mycobacterium species
studied. All isolates investigated here had previously been
assigned M. kansasii (n = 27) or M. chelonae–M. abscessus (n = 29)
by phenotypic methods and a DNA-based commercial LiPA assay.19
For all isolates of M. kansasii the three methods provided identical
species identiﬁcation (100% concordance), whereas 27 out of 29
(93%) M. chelonae–M. abscessus group isolates were correctly
identiﬁed by PRA. For two (7%) isolates, PRA could not yield a
species assignment since their patterns have not been reported so
far. No discrepancies were observed between the results of the
three methods used. With the overall agreement of 96.4%, PRA has
proven to be similarly effective, as found in other studies.16–18
Moreover, PRA proved superior to both conventional tests and the
molecular LiPA assay in enabling differentiation of the M. chelonae–
M. abscessus group member species. Our bioanalyzer system-based
PRA currently identiﬁes 35 different Mycobacterium species, and
this number will likely increase in the future as new reference
strains are included.20
PRA analysis of M. kansasii isolates allowed us to detect ﬁve out
of six currently deﬁned genetic types within this species,16
originally described by Picardeau et al. in 1997.23 Thus, our data
conﬁrm and extend prior reports on the heterogeneity within M.
kansasii and the distribution of different types.2,18,23–25
Members of the M. chelonae–M. abscessus group are often not
distinguished by clinical laboratories, despite the fact that they
cause diseases requiring different treatment regimens. In thisstudy, isolates of the individual species and genotypes within
species were easily identiﬁed by PRA. Unexpectedly, the vast
majority – 11 out of 16 (69%) – of the isolates from humans were
identiﬁed as M. immunogenum. However, only one of them was
clinically signiﬁcant causing pulmonary disease (isolated from a
sputum specimen), whereas the other 10 isolates were recovered
from respiratory specimens obtained by bronchoscopes and were
considered to be contaminants. Our results indicate that the
occurrence of M. immunogenum, one of the new member species of
the M. chelonae–M. abscessus group,6 in culture collections
previously classiﬁed as M. chelonae/M. abscessus is likely under-
estimated. In contrast, M. chelonae were the most frequent (83%)
environmental (water) isolates in the present study. In contrast to
previously published data,17,26 in this study M. chelonae and M.
abscessus were rarely associated with pulmonary infections, but
the observed difference was most likely due to a lower number of
isolates examined here and/or the sample bias.
Among 29 M. chelonae–M. abscessus group isolates studied here,
two (7%) yielded PRA patterns not previously reported. Sequence
analysis of the variable regions of the hsp65 and rpoB genes, which
proved highly effective for the differentiation of mycobacteria,14,27
identiﬁed one of these isolates as M. salmoniphilum, a species
closely related to M. chelonae.28 The other isolate showed
inconclusive results: M. immunogenum by hsp65 sequence analysis
and M. immunogenum or M. chelonae by rpoB sequence analysis.
Several recent studies have reported similar problems with the
discrimination of M. abscessus, M. massiliense, and M. bolletii. The
authors reported a number of isolates showing ambiguous
identiﬁcation by partial sequencing of rpoB, hsp65, and sodA29,30
or secA.12 Very recently, Macheras et al. reported 15 out of 59
clinical isolates with discordant nucleotide sequences of rpoB,
hsp65, and sodA. Even sequence analysis of an additional ﬁve
housekeeping genes did not result in unambiguous identiﬁcation
of two of the isolates studied. The authors hypothesized that such a
composite genetic structure of certain M. abscessus group isolates
most probably resulted from genetic exchange among the member
species.13
Our results on reference strains as well as test isolates of M.
kansasii and M. chelonae–M. abscessus group proved that the PRA
method based on ﬂuorescence capillary electrophoresis could
efﬁciently identify and differentiate the individual species and
genetic types within species isolated from diverse sources and
geographical areas. Although relatively expensive, which might
limit its wide use, this molecular method is simple, fast, and
reliable and thus appears a suitable format for performance of both
PCR-based identiﬁcation and typing of NTM. This is of particular
importance on the background of the predicted increasing
incidence of interactions between humans and mycobacteria in
coming years, which will likely result in more clinical cases of NTM.
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